Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication
- DOI
- 10.1016/j.yrtph.2019.104433
- Published
- 2019-11
- Container
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.yrtph.2019.104433,
title = {Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication},
author = {P.S. Joshi and N. Sanakkayala and L. Kirkpatrick and P.S. Terse},
year = {2019},
journal = {Regulatory Toxicology and Pharmacology},
doi = {10.1016/j.yrtph.2019.104433},
url = {https://doi.org/10.1016/j.yrtph.2019.104433}
}RIS
TY - JOUR TI - Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication AU - P.S. Joshi AU - N. Sanakkayala AU - L. Kirkpatrick AU - P.S. Terse PY - 2019 JO - Regulatory Toxicology and Pharmacology DO - 10.1016/j.yrtph.2019.104433 UR - https://doi.org/10.1016/j.yrtph.2019.104433 ER -
APA
Joshi, P., Sanakkayala, N., Kirkpatrick, L., & Terse, P. (2019). Nonclinical safety assessment of PF614: A novel TAAP prodrug of oxycodone for chronic pain indication. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2019.104433
Source records
- crossref · retrieved 2026-09-26T19:38:44.499Z